Cargando…
Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes
[Image: see text] Isocitrate dehydrogenase is mutated at a key active site arginine residue (Arg172 in IDH2) in many cancers, leading to the synthesis of the oncometabolite (R)-2-hydroxyglutarate (2HG). To investigate the early events following acquisition of this mutation in mammalian cells we crea...
Autores principales: | Walker, Olivia S., Elsässer, Simon J., Mahesh, Mohan, Bachman, Martin, Balasubramanian, Shankar, Chin, Jason W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2016
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821487/ https://www.ncbi.nlm.nih.gov/pubmed/26761588 http://dx.doi.org/10.1021/jacs.5b07627 |
Ejemplares similares
-
Adult isocitrate dehydrogenase–mutant brainstem glioma: illustrative case
por: Ye, Vincent C., et al.
Publicado: (2021) -
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
por: Golub, Danielle, et al.
Publicado: (2019) -
Genetic Encoding of Photocaged Cysteine Allows Photoactivation
of TEV Protease in Live Mammalian Cells
por: Nguyen, Duy P., et al.
Publicado: (2014) -
Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis
por: OHBA, Shigeo, et al.
Publicado: (2016) -
Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)